Signalling via CD70, a member of the TNF family, regulates T cell functions

Journal of Leukocyte Biology

Volumn 76, Issue 1, 2004, Pages 263-270

  García, Pilar ^a   Beltrán De Heredia, Agustín ^b   Bellón, Teresa ^a   Carpio, Emilio ^b   Llano, Manuel ^a   Caparrós, Esther ^b   Aparicio, Pedro ^b   López Botet, Miguel ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

CD27L; Cytotoxicity; Human; NK cell; Signal transduction; T lymphocyte

Indexed keywords

CD27 ANTIGEN; CD30 ANTIGEN; CD40 LIGAND; CD70 ANTIBODY; CD70 ANTIGEN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION SYSTEM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; LYMPHOCYTE CLONE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD27; ANTIGENS, CD70; BLOTTING, WESTERN; CALCIUM; CERCOPITHECUS AETHIOPS; COS CELLS; CROSS-LINKING REAGENTS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PRECIPITIN TESTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION;

EID: 3042781026     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1003508     Document Type: Article

References (44)

1. Goodwin, R. G., Alderson, M. R., Smith, C. A., Armitage, R. J., Van den Bos, T., Jerzy, R., Tough, T. W., Schoenborn, M. A., Davis-Smith, T., Hennen, K. (1993) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73, 447-456.
2. Hintzen, R. Q., Lens, S. M., Beckmann, M. P., Goodwin, R. G., Lynch, D., van Lier, R. A. (1994) Characterization of the human CD27 ligand, a novel member of the TNF gene family. J. Immunol. 152, 1762-1773.
3. Bowman, M. R., Crimmins, M. A., Yetz-Aldape, J., Kriz, R., Kelleher, K., Herrmann, S. (1994) The cloning of CD70 and its identification as the ligand for CD27. J. Immunol. 152, 1756-1761.
4. Oshima, H., Nakano, H., Nohara, C., Kobata, T., Nakajima, A., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Muto, T., Yagita, H., Okumura, K. (1998) Characterization of murine CD70 by molecular cloning and mAb. Int. Immunol. 10, 517-526.
5. Tesselaar, K., Gravestein, L. A., van Schijndel, G. M., Borst, J., van Lier, R. A. (1997) Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 159, 4959-4965.
6. Camerini, D., Walz, G., Loenen, W. A., Borst, J., Seed, B. (1991) The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147, 3165-3169.
7. Hintzen, R. Q., de Jong, R., Lens, S. M., van Lier, R. A. (1994) CD27: marker and mediator of T-cell activation? Immunol. Today 15, 307-311.
8. van Lier, R. A., Borst, J., Vroom, T. M., Klein, H., van Mourik, P., Zeijlemaker, W. P., Melief, C. J. (1987) Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139, 1589-1596.
9. Tesselaar, K., Xiao, Y., Arens, R., van Schijndel, G. M., Schuurhuis, D. H., Mebius, R. E., Borst, J., van Lier, R. A. (2003) Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170, 33-40.
10. Hamann, D., Baars, P. A., Rep, M. H., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., van Lier, R. A. (1997) Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med. 186, 1407-1418.
11. Lens, S. M., Tesselaar, K., van Oers, M. H., van Lier, R. A. (1998) Control of lymphocyte function through CD27-CD70 interactions. Semin. Immunol. 10, 491-499.
12. Brown, G. R., Meek, K., Nishioka, Y., Thiele, D. L. (1995) CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes. J. Immunol. 154, 3686-3695.
13. Hintzen, R. Q., Lens, S. M., Lammers, K., Kuiper, H., Beckmann, M. P., van Lier, R. A. (1995) Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154, 2612-2623.
14. Gravestein, L. A., Nieland, J. D., Kruisbeek, A. M., Borst, J. (1995) Novel mAbs reveal potent co-stimulatory activity of murine CD27. Int. Immunol. 7, 551-557.
15. Akiba, H., Nakano, H., Nishinaka, S., Shindo, M., Kobata, T., Atsuta, M., Morimoto, C., Ware, C. F., Malinin, N. L., Wallach, D., Yagita, H., Okumura, K. (1998) CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-κB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-κB-inducing kinase. J. Biol. Chem. 273, 13353-13358.
16. Arens, R., Tesselaar, K., Baars, P. A., van Schijndel, G. M., Hendriks, J., Pals, S. T., Krimpenfort, P., Borst, J., van Oers, M. H., van Lier, R. A. (2001) Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion. Immunity 15, 801-812.
17. Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., Smyth, M. J. (2002) Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3, 83-90.
18. Yang, F. C., Agematsu, K., Nakazawa, T., Mori, T., Ito, S., Kobata, T., Morimoto, C., Komiyama, A. (1996) CD27/CD70 interaction directly induces natural killer cell killing activity. Immunology 88, 289-293.
19. Hendriks, J., Gravestein, L. A., Tesselaar, K., van Lier, R. A., Schumacher, T. N., Borst, J. (2000) CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1, 433-440.
20. Brenner, B., Koppenhoefer, U., Grassme, H., Kun, J., Lang, F., Gulbins, E. (1997) Evidence for a novel function of the CD40 ligand as a signalling molecule in T-lymphocytes. FEBS Lett. 417, 301-306.
21. Brenner, B., Koppenhoefer, U., Lepple-Wienhues, A., Grassme, H., Muller, C., Speer, C. P., Lang, F., Gulbins, E. (1997) The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation. Biochem. Biophys. Res. Commun. 239, 11-17.
22. Wiley, S. R., Goodwin, R. G., Smith, C. A. (1996) Reverse signaling via CD30 ligand. J. Immunol. 157, 3635-3639.
23. Carbone, E., Ruggiero, G., Terrazzano, G., Palomba, C., Manzo, C., Fontana, S., Spits, H., Karre, K., Zappacosta, S. (1997) A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185, 2053-2060.
24. Lens, S. M., Drillenburg, P., den Drijver, B. F., van Schijndel, G., Pals, S. T., van Lier, R. A., van Oers, M. H. (1999) Aberrant expression and reverse signalling of CD70 on malignant B cells. Br. J. Haematol. 106, 491-503.
25. Orengo, A. M., Cantoni, C., Neglia, F., Biassoni, R., Ferrini, S. (1997) Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity. Clin. Exp. Immunol. 107, 608-613.
26. Llano, M., Lee, N., Navarro, F., García, P., Albar, J. P., Geraghty, D. E., López-Botet, M. (1998) HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28, 2854-2863.
27. Bellón, T., Heredia, A. B., Llano, M., Minguela, A., Rodríguez, A., López-Botet, M., Aparicio, P. (1999) Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer. J. Immunol. 162, 3996-4002.
28. Aramburu, J., Balboa, M. A., Ramírez, A., Silva, A., Acevedo, A., Sánchez-Madrid, F., de Landázuri, M. O., López-Botet, M. (1990) A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-γ/δ+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 144, 3238-3247.
29. Pérez-Villar, J. J., Melero, I., Rodríguez, A., Carretero, M., Aramburu, J., Sivori, S., Orengo, A. M., Moretta, A., López-Botet, M. (1995) Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 154, 5779-5788.
30. Vicente-Manzanares, M., Rey, M., Jones, D. R., Sancho, D., Mellado, M., Rodríguez-Frade, J. M., del Pozo, M. A., Yáñez-Mo, M., de Ana, A. M., Martínez, A., Mérida, I., Sánchez-Madrid, F. (1999) Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 α-induced lymphocyte polarization and chemotaxis. J. Immunol. 163, 4001-4012.
31. Chang, C., Rodríguez, A., Carretero, M., López-Botet, M., Phillips, J. H., Lanier, L. L. (1995) Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 25, 2433-2437.
32. Hedin, K. E., Bell, M. P., Kalli, K. R., Huntoon, C. J., Sharp, B. M., McKean, D. J. (1997) δ-Opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J. Immunol. 159, 5431-5440.
33. Aramburu, J., Yaffe, M. B., Lopez-Rodriguez, C., Cantley, L. C., Hogan, P. G., Rao, A. (1999) Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285, 2129-2133.
34. Wei, S., Gilvary, D. L., Corliss, B. C., Sebti, S., Sun, J., Straus, D. B., Leibson, P. J., Trapani, J. A., Hamilton, A. D., Weber, M. J., Djeu, J. Y. (2000) Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway. J. Immunol. 165, 3811-3819.
35. Carretero, M., Llano, M., Navarro, F., Bellón, T., López-Botet, M. (2000) Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E. Eur. J. Immunol. 30, 2842-2848.
36. Macián, F., Garcia-Rodríguez, C., Rao, A. (2000) Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 19, 4783-4795.
37. Watts, A. D., Hunt, N. H., Wanigasekara, Y., Bloomfield, G., Wallach, D., Roufogalis, B. D., Chaudhri, G. (1999) A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in "reverse signaling". EMBO J. 18, 2119-2126.
38. Jiang, K., Zhong, B., Gilvary, D. L., Corliss, B. C., Hong-Geller, E., Wei, S., Djeu, J. Y. (2000) Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1, 419-425.
39. Fuller, C. L., Ravichandran, K. S., Braciale, V. L. (1999) Phosphatidylinositol 3-kinase-dependent and -independent cytolytic effector functions. J. Immunol. 162, 6337-6340.
40. Koyasu, S. (2003) The role of PI3K in immune cells. Nat. Immunol. 4, 313-319.
41. Agematsu, K., Kobata, T., Sugita, K., Hirose, T., Schlossman, S. F., Morimoto, C. (1995) Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. J. Immunol. 154, 3627-3635.
42. Jacquot, S., Macon-Lemaitre, L., Paris, E., Kobata, T., Tanaka, Y., Morimoto, C., Schlossman, S. F., Tron, F. (2001) B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. Int. Immunol. 13, 871-876.
43. Brouet, J. C., Chedeville, A., Fermand, J. P., Royer, B. (2000) Study of the B cell memory compartment in common variable immunodeficiency. Eur. J. Immunol. 30, 2516-2520.
44. Groth, C., Drager, R., Warnatz, K., Wolff-Vorbeck, G., Schmidt, S., Eibel, H., Schlesier, M., Peter, H. H. (2002) Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID). Clin. Exp. Immunol. 129, 133-139.